🧬 Retatrutide 30mg – High‑Purity Research Peptide Product Overview Retatrutide is a synthetic triple‑agonist research peptide used in studies involving GIP, GLP‑1, and glucagon receptor signalling. Its multi‑pathway profile makes it a key molecule of interest in metabolic regulation, appetite signalling, glucose utilisation, and energy‑balance research models. Our Retatrutide 30mg is supplied as a high‑purity lyophilised peptide, suitable for laboratory, academic, and in‑vitro research applications. Key Research Areas Triple‑agonist metabolic signalling Energy expenditure & balance models Appetite regulation pathways Glucose metabolism research Body‑weight regulation mechanisms Multi‑pathway metabolic modulation Product Specifications Peptide: Retatrutide Strength: 30mg Form: Lyophilised powder Purity: ≥ 98% (HPLC tested) Appearance: White powder Storage: Refrigerated; avoid heat exposure Packaging: Sterile, sealed research vial Use: For laboratory research only Research Insights Triple‑Agonist Activity Retatrutide is studied for its simultaneous interaction with GIP, GLP‑1, and glucagon receptors, offering a unique multi‑pathway profile in metabolic research. Metabolic Regulation Research models explore how Retatrutide influences energy expenditure, appetite signalling, and glucose utilisation. Body‑Weight Mechanisms Retatrutide is used in experimental setups examining weight‑modulation pathways and multi‑agonist metabolic responses. Why Choose CRC Research? UK‑based research peptide supplier High‑purity peptides with verified testing Fast dispatch and secure packaging Trusted by academic and laboratory researchers Important Notice This product is strictly for laboratory research use only. Not for human consumption, medical use, or diagnostic use. Frequently Asked Questions Is Retatrutide legal to purchase in the UK Yes — Retatrutide can be purchased for research purposes only. Does Retatrutide require cold storage Yes. It should be kept refrigerated to maintain stability. What type of research uses Retatrutide Retatrutide is commonly used in studies involving triple‑agonist metabolic pathways, appetite regulation, and energy‑balance research.